Emcure Pharmaceuticals Ltd Nine Monthly Results

Gross Sales

5,779.75

4,886.9

Excise Duty

0

0

Net Sales

5,779.75

4,886.9

Other Operating Income

0

0

Other Income

55.86

45.25

Total Income

5,835.61

4,932.15

Total Expenditure

4,700.82

3,978.32

PBIDT

1,134.79

953.83

Interest

136.76

171.66

PBDT

998.03

782.17

Depreciation

287.29

221.84

Minority Interest Before NP

0

0

Tax

200.6

180.95

Deferred Tax

-0.1

-27.18

Reported Profit After Tax

510.23

406.56

Minority Interest After NP

17.86

23.54

Net Profit after Minority Interest

492.38

383.02

Extra-ordinary Items

0

-6.63

Adjusted Profit After Extra-ordinary item

492.38

389.65

EPS (Unit Curr.)

26.44

21.18

Book Value (Unit Curr.)

0

0

Dividend (%)

0

0

Equity

189.43

180.85

Public Shareholding (Number)

0

0

Public Shareholding (%)

0

0

Pledged/Encumbered - No. of Shares

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

Pledged/Encumbered - % in Total Equity

0

0

Non Encumbered - No. of Shares

0

0

Non Encumbered - % in Total Promoters Holding

0

0

Non Encumbered - % in Total Equity

0

0

PBIDTM(%)

19.63

19.51

PBDTM(%)

17.26

16

PATM(%)

8.82

8.31